cTIV + PV

cTIV + PV appears to refer to a combination of two influenza vaccines used in clinical research or immunization programs. "cTIV" typically stands for "cell-based trivalent influenza vaccine," while "PV" may refer to a "placebo vaccine" or, less commonly, a specific type of vaccine such as a pneumococcal vaccine. However, based on the context and standard usage in clinical trials, it is most likely that cTIV + PV refers to the administration of both cell-based trivalent influenza vaccine and placebo (or another comparator vaccine) as part of an immunization regimen. The cell-based trivalent influenza vaccine works by stimulating the immune system to produce antibodies against three strains of the influenza virus (two A subtypes and one B subtype), providing protection against seasonal flu.